Sky News: BioAge's unique approach to targeting aging

Описание: On Nov.14, 2022, Sky News editor Tom Clarke interviewed BioAge CEO Kristen Fortney to discuss how BioAge analyzes human aging cohorts to identify the key molecular pathways underlying healthy longevity. Kristen tells Tom about one of the most exciting programs in BioAge's growing portfolio - the apelin receptor agonist BGE-105, under development for muscle aging indications.